 ?您的位置：對照品 > 對照品 > 中檢所對照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：B400005 |
| 產(chǎn)品名稱：(16β)-17,21-Bis(acetyloxy)-16-methyl-pregna-1,4,9(11)-triene-3,20-dione |
| 產(chǎn)品CAS：65535-36-6 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
B400005 |
| 名稱: |
(16β)-17,21-Bis(acetyloxy)-16-methyl-pregna-1,4,9(11)-triene-3,20-dione |
| CAS號: |
65535-36-6 |
| 分子式: |
C??H??O? |
| 外觀： |
白色固體 |
| 分子量: |
440.53 |
| 溶解度: |
Dichloromethane |
| 類別: |
Standards; Steroids; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
(16β)-17,21-Bis(acetyloxy)-16-methyl-pregna-1,4,9(11)-triene-3,20-dione is an intermediate in the synthesis of (16β)-17,21-Dihydroxy-16β-methyl-pregna-1,4,9(11)-triene-3,20-dione which is used in biological studies to perform preclinical characterization of VBP15, a novel anti-inflammatory delta 9,11 steroid. This compound is also used in analytical studies to determine the stability from reversed-phase high performance liquid chromatography (RP-HPLC) to separate low levels of dexamethasone and other related compounds from betametasone, which is an active pharmaceutical ingredient. |
| 文獻 |
|
|
|
|
|
|
